ArticleTherapeutic advances in gastroenterology2019

Anti-tumour necrosis factor discontinuation in inflammatory bowel disease patients in remission: study protocol of a prospective, multicentre, randomized clinical trial.

María Chaparro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.